Overview
Salah Almokadem is a Hematologist Oncology specialist and a Hematologist in Fremont, Michigan. Dr. Almokadem is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma.
His clinical research consists of co-authoring 9 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
230 W Oak St, Corewell Health Gerber Hos, Fremont, MI 49412
300 N Patterson Rd, Corewell Health Reed City, Reed City, MI 49677
4499 220th Ave, Reed City, MI 49677
1 Atkinson Dr, Ludington, MI 49431
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Advantage Health/saint Mary's Medical Group
Peter Van Veldhuizen is a Hematologist Oncology specialist and a Hematologist in Grand Rapids, Michigan. Dr. Van Veldhuizen is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), and Wilms Tumor. Dr. Van Veldhuizen is currently accepting new patients.
Spectrum Health Primary Care Partners
Emerson Lim is an Oncologist in Kentwood, Michigan. Dr. Lim is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Lim is currently accepting new patients.
Mclaren Central Michigan
Elias Zeine is a Hematologist and an Oncologist in Mount Pleasant, Michigan. Dr. Zeine is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Bone Marrow Aspiration. Dr. Zeine is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Almokadem isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Almokadem isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Almokadem isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Almokadem isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Almokadem isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Almokadem isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Chromophobe Renal Cell CarcinomaDr. Almokadem isAdvanced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Almokadem isAdvanced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Almokadem isAdvanced. Learn about Familial Wilms Tumor 2.
- Laryngeal CancerDr. Almokadem isAdvanced. Learn about Laryngeal Cancer.
- MesotheliomaDr. Almokadem isAdvanced. Learn about Mesothelioma.
- Neuroendocrine TumorDr. Almokadem isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Acute Myeloblastic Leukemia with MaturationDr. Almokadem isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Almokadem isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Myelomonocytic LeukemiaDr. Almokadem isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Acute Promyelocytic LeukemiaDr. Almokadem isExperienced. Learn about Acute Promyelocytic Leukemia.
- Adult Soft Tissue SarcomaDr. Almokadem isExperienced. Learn about Adult Soft Tissue Sarcoma.